Talkspace (TALK) to Release Earnings on Tuesday
by Renee Jackson · The Cerbat GemTalkspace (NASDAQ:TALK – Get Free Report) is set to announce its quarterly earnings data before the market opens on Tuesday, October 29th. Analysts expect the company to announce earnings of ($0.01) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.
Talkspace Price Performance
TALK stock opened at $2.78 on Monday. Talkspace has a 1-year low of $1.41 and a 1-year high of $3.92. The business has a 50 day simple moving average of $2.16 and a two-hundred day simple moving average of $2.36. The company has a market capitalization of $467.62 million, a price-to-earnings ratio of -55.60 and a beta of 1.21.
Insider Buying and Selling at Talkspace
In other news, CFO Ian Jiro Harris acquired 23,100 shares of the firm’s stock in a transaction dated Thursday, September 19th. The shares were acquired at an average cost of $2.11 per share, with a total value of $48,741.00. Following the acquisition, the chief financial officer now directly owns 397,657 shares of the company’s stock, valued at approximately $839,056.27. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 21.70% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
Separately, Needham & Company LLC reaffirmed a “hold” rating on shares of Talkspace in a research note on Tuesday, August 6th.
Check Out Our Latest Stock Report on Talkspace
About Talkspace
Talkspace, Inc operates as a virtual behavioral healthcare company in the United States. The company offers psychotherapy and psychiatry services through its platform to individuals, enterprises, and health plans and employee assistance programs. It provides text, audio, and video-based psychotherapy from licensed therapists.
See Also
- Five stocks we like better than Talkspace
- The 3 Best Retail Stocks to Shop for in August
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- 3 Healthcare Dividend Stocks to Buy
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?